Cipla reported a 35% year-on-year decline in second-quarter net profit to Rs 878 crore, with revenue and EBITDA also falling amid weaker North American sales. India revenue grew 12%, while US regulatory approval and a biosimilar partnership supported its product pipeline.
Cipla reported a 35% year-on-year decline in second-quarter net profit to Rs 878 crore, with revenue and EBITDA also falling amid weaker North American sales. India revenue grew 12%, while US regulatory approval and a biosimilar partnership supported its product pipeline.
<iframe src="https://hindustansphere.com/embed/cluster/6734bee4df1faaeacce91186f07e7ceda6c73bb1" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Cipla Q2 net profit falls 35% to Rs 878 crore, revenue dips 2%"></iframe>
